Secondly, our exploration about effects of TRIM9 on cell biological processes showed that TRIM9 promoted bladder cancer proliferation, migration and chemoresistance via CEACAM6/Smad2/3 signaling. The gene discussed is SMAD2; the disease is urinary bladder carcinoma.